{
    "organizations": [],
    "uuid": "2d945443912f8107f0833917b5ad113c8fc53ef7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-jubilant-life-sciences-says-unit-g/brief-jubilant-life-sciences-says-unit-got-anda-approval-for-clonidine-hydrochloride-extended-release-tablets-idUSFWN1PP07A",
    "ord_in_thread": 0,
    "title": "BRIEF-Jubilant Life Sciences Says Unit Got ANDA Approval For Clonidine Hydrochloride Extended-Release Tablets‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Jubilant Life Sciences Ltd:\n* JUBILANT PHARMA GOT ANDA APPROVAL FOR CLONIDINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS‍​ Source text: bit.ly/2Gt6DoZ Further company coverage:\n ",
    "published": "2018-01-30T15:28:00.000+02:00",
    "crawled": "2018-01-31T16:46:10.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "jubilant",
        "life",
        "science",
        "ltd",
        "jubilant",
        "pharma",
        "got",
        "anda",
        "approval",
        "clonidine",
        "hydrochloride",
        "source",
        "text",
        "company",
        "coverage"
    ]
}